Segall Bryant & Hamill’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-17,974	Closed	-$20K	–	844
2019 Q2	$20K	Buy	+17,974	New	+$20K	﹤0.01%	808
2019 Q1	–	Sell	-13,383	Closed	-$12K	–	850
2018 Q4	$12K	Buy	+13,383	New	+$12K	﹤0.01%	816